BACH1 and Parkinson disease: Our promising results with genetic and pharmacological approaches to inhibit Bach1 in PD mouse models warrants further investigation into the validation of Bach1 inhibition as an alternate strategy for developing safer and more effective therapeutic interventions for PD and other chronic neurodegenerative diseases.